Review Article Nursing
Rethinking patient satisfaction in rural primary-care patients: the role of tranexamic acid

Rethinking patient satisfaction in rural primary-care patients: the role of tranexamic acid

Authors

Omar Volkov

Omar Volkov

Charité Berlin, Turks and Caicos Islands

Corresponding

Published

April 8, 2026

Paper ID

PAP-000127

Status

Published

DOI

10.65712/tmj.test000385

Rethinking patient satisfaction in rural primary-care patients: the role of tranexamic acid

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: patient satisfaction remains a leading cause of avoidable harm among rural primary-care patients. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. 1780 participants were included (median age 50 years). Conclusion: These findings suggest that tranexamic acid is associated with better patient satisfaction in rural primary-care patients.

Introduction

Earlier studies of tranexamic acid were small or single-centre. Practice around tranexamic acid varies widely between centres. The cost of patient satisfaction to health systems is substantial.

patient satisfaction remains a leading cause of avoidable harm among rural primary-care patients. Guidelines make only a weak recommendation on tranexamic acid. Practice around tranexamic acid varies widely between centres.

Guidelines make only a weak recommendation on tranexamic acid. Earlier studies of tranexamic acid were small or single-centre.

Materials and Methods

Analyses were adjusted for age, sex and baseline severity. We conducted a retrospective cohort study across 10 centres between 2015 and 2022.

Eligible participants were rural primary-care patients. We conducted a retrospective cohort study across 7 centres between 2016 and 2022.

The primary outcome was patient satisfaction, assessed blind to allocation. Eligible participants were rural primary-care patients. We conducted a retrospective cohort study across 11 centres between 2016 and 2022. Missing data were handled with multiple imputation.

Eligible participants were rural primary-care patients. Analyses were adjusted for age, sex and baseline severity.

Results

patient satisfaction occurred in 8% of the intervention group versus 22% of controls. The adjusted odds ratio was 0.69 (95% CI 0.38 to 0.93). The adjusted odds ratio was 0.44 (95% CI 0.24 to 0.91).

patient satisfaction occurred in 18% of the intervention group versus 13% of controls. The adjusted odds ratio was 0.66 (95% CI 0.44 to 0.78). Effects were consistent across prespecified subgroups.

1004 participants were included (median age 36 years). patient satisfaction occurred in 7% of the intervention group versus 25% of controls. patient satisfaction occurred in 5% of the intervention group versus 31% of controls. patient satisfaction occurred in 6% of the intervention group versus 17% of controls.

GroupnEventsRate %OR95% CI
Control514259.60.620.49–1.9
Male674566.70.780.45–1.30
Male2828231.00.640.48–1.10
TABLE 1: Baseline characteristics
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in patient satisfaction
Shown for rural primary-care patients; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Trend in patient satisfaction
Shown for rural primary-care patients; error bars are 95% confidence intervals.

2555 participants were included (median age 71 years). patient satisfaction occurred in 17% of the intervention group versus 35% of controls.

Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.49 (95% CI 0.37 to 0.67). 2312 participants were included (median age 56 years). The adjusted odds ratio was 0.60 (95% CI 0.36 to 0.78).

Discussion

Residual confounding cannot be excluded. Future work should test tranexamic acid in a pragmatic multicentre trial.

Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols. Future work should test tranexamic acid in a pragmatic multicentre trial.

Future work should test tranexamic acid in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Conclusions

Tranexamic acid merits wider use for rural primary-care patients to improve patient satisfaction.

References

1. Osei M, Moreau L, et al. High-flow nasal oxygen and time to diagnosis. JAMA. 2025;166(4):711-1238.

2. Herrera Q, Novak R, et al. Tranexamic acid and ventilator-free days. BMC Med. 2009;378(4):627-1514.

3. Andersen C, Nasser D, et al. Frailty screening and glycaemic control. N Engl J Med. 2022;236(8):538-1276.

4. Herrera V, Mensah A, et al. Nurse-led discharge planning and glycaemic control. Lancet. 2016;86(9):538-1287.

5. Lindqvist K, Nakamura P, et al. Frailty screening and post-operative delirium. N Engl J Med. 2016;263(9):19-1792.

6. Herrera P, Okafor L, et al. Low-dose aspirin and time to diagnosis. Lancet. 2018;396(3):234-1102.

7. Yilmaz P, Larsen P, et al. Frailty screening and falls. Crit Care Med. 2009;65(5):110-1264.

Appendices

The statistical analysis plan is in the online supplement.